HBOT Conversations:
Dr. Hemal Mehta & Fasting (Part 1)

Dr. Hemal Mehta, MD is a Medical Director and an Independent Medical Examiner who focuses on pain management through a Regenerative medicine approach.

Dr. Mehta is Board Certified in Physical Medicine and Pain Management. He received his Doctor of Medicine Degree from Ross University School of Medicine and completed his residency at East Carolina. He is the Medical Director of Vibrant Health of North Carolina, Tennessee Integrative Pain Institute, and TN Integrative Healthcare:  Musculoskeletal and Regenerative Center; additionally, Dr. Mehta is the attending physician at Nashville Regenerative Orthopedics.

Dr. Mehta is the 2013 recipient of the Inaugural Patient Appreciation Award at Nashville Academy of Medicine, and the 2004 Research Resident of the Year for East Carolina University.

Dr. Mehta has extensive experience with stem cell proliferation, and angiogenesis.  He has incorporated Ozone Injection Therapy, PRP (Platelet-Rich Plasma) Injections, Hyperbaric Oxygen Therapy and Regenerative Matrix and Regenerative Medicine Procedures – to name a few – into his integrative wellness & longevity medical practices.

Subscribe. Join the discussion. Share the hope.

Watch the Podcast

HBOT News Network welcomes Dr. Hemal V. Mehta, M.D.; Medical Director of Vibrant Health of North Carolina.

After the first 10-15 years of his medical career focusing on interventional pain management, Dr. Mehta started to get involved in regenerative medicine. Regenerative medicines is a newer field of medicine involving PRP – Platelet Rich Plasma, stem cells, and different techniques (like HBOT) to help regenerate tissue in the body. When he first started using regenerative medicine, Dr. Mehta witnessed his patients doing considerably better and improving to the point that he was able to even wean them off of opioid pain medications. It was then that Dr. Mehta started integrating Hyperbaric Oxygen Therapy (HBOT or HBO Therapy) into some of the individualized patient healing plans he would develop for optimum healing.

Dr. Mehta touches on inflammation and how inflammation is one of the greatest problems people today deal with on a daily basis. Bad food choices, injuries and even stress all contributes to an increase of inflammation.  Targeting inflammation is key to a healthy body and mind.  Hyperbaric oxygen is an ideal therapy to address inflammation by upregulating the anti-inflammatory gene and downregulating the inflammatory gene.  Dr. Mehta also mentions other therapies that assist in reducing inflammation in the joints and body — regenerative treatments using stem cells, PRP, ozone injections and exosomes.

According to Dr. Mehta, too much focus and energy goes into the promotion of pharmaceutical drugs to ease every ailment, indication or condition. He mentioned that when he was studying for his medical degree, he had almost two years of pharmacology classes but only one six-week semester of nutrition.  It’s unfortunate that nutrition is not stressed more to young doctors, because much of the food we purchase at the grocery store is toxic and very pro-inflammatory.  Dr. Mehta stresses that “you are what you eat”.  Processed food is one of the worst things for our bodies. In his opinion, processed food is a major oxygen depleter since our bodies have to use extra energy and oxygen to break it down. Our bodies have to work much harder to break down processed junk, so he encourages our viewers to eat foods that are natural and avoid processed.

Since nutrition is a HUGE part of a person’s health, it’s important to look at alternatives to pharmaceutical drugs – like Hyperbaric Oxygen Therapy and fasting. In Dr. Mehta’s opinion, fasting is an excellent way for people to maintain health. Our bodies don’t necessarily NEED 3 meals a day, so when we overeat our bodies store the excess. Dr. Mehta is a big believer in fasting and reminds us that fasting is the ultimate detox. Food, especially processed food, sugar, and food with high fructose corn syrup, can be very pro-inflammatory and toxic. Fasting accelerates the process of the liver cleaning out toxins and gives our organs a much needed break to heal and rejuvenate. Fasting dates back to the Bible and beyond – every religious facet has fasting as part of their religion.

Fasting is nothing new, so try it and add Hyperbaric Oxygen Therapy into the mix too; something magical is truly happening to the body when you fast and receive HBOT. Dr. Mehta reminds us that there is also a strong association between fasting and reduced cancer risk, which he will get into more in Part 2 of our Conversations with Dr. Mehta about fasting & HBOT.  Stay tuned to learn more about how fasting starves the cancer cells from the sugars and nutrients they need to feed and grow.

*Pease consult your doctor to see if fasting is right for you.

Guest

Robert Beckman

Dr. Hemal Mehta

Dr. Hemal Mehta specializes in non-opioid treatment for joint pain, osteoarthritis, spine pain and neuropathy. He is a board-certified Physical Medicine and Rehabilitation physician whose goal for patients is to reduce pain while increasing their level of function & quality of life. He received his Doctor of Medicine Degree from Ross University School of Medicine and completed his residency at East Carolina.

Dr. Mehta is the Medical Director of Vibrant Health of North Carolina, Tennessee Integrative Pain Institute, and TN Integrative Healthcare:  Musculoskeletal and Regenerative Center; additionally, Dr. Mehta is the attending physician at Nashville Regenerative Orthopedics. He is the 2013 recipient of the Inaugural Patient Appreciation Award at Nashville Academy of Medicine, and the 2004 Research Resident of the Year for East Carolina University. He is a member of the American Academy of Physical Medicine & Rehabilitation, American Society of Interventional Pain Physicians, and American Association of Neuromuscular and Electrodiagnostic Medicine.

Dr. Mehta has extensive experience with stem cell proliferation and angiogenesis. For years he has incorporated Hyperbaric Oxygen Therapy into his integrative approach for pain management and rehabilitation, and he has also preformed the following procedures fluoroscopically: Translaminar Cervical and Lumbar ESI, Transforaminal Lumbar ESI, Lumbar Selective Nerve Root Blocks, Stellate Ganglion Blocks, Lumbar Sympathetic Blocks, SIJ injections, Hip Joint Injections, Piriformis Injections, Cervical and Lumbar Facet Joint Injections, Medial Branch Nerve Blocks, Radiofrequency Ablation of Medial Branch Nerve, Discography, Percutaneous Disc Decompression/ Intradiscal Injections, Spinal Cord Stimulator Lead Trial, PRP/ Regenerative Matrix/ Regenerative Medicine Procedures for Spine, Peripheral Joints, and Nerves, P-Shot/O-shot, Juvederm Anti-aging, and Ozone Injection Therapy.

Subscribe Now, It’s Free!

[contact-form-7 id="65934" title="Subscribe"]

Recent HBOT News

Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing Crohn’s disease.

Fistulizing Crohn’s disease (CD) presents a therapeutic challenge as fistulae are notoriously difficult to heal. Mycobacterium avium ss paratuberculosis (MAP) treatment in CD is gaining attention. We evaluated healing of CD fistula(e) using a novel combination therapy. Nine consecutive patients who failed to heal fistulae on conventional treatment including anti-TNF, were treated with at least three doses of infliximab, 18-30 courses of hyperbaric oxygen therapy and anti-MAP antibiotics comprising rifabutin, clarithromycin and clofazimine. All patients achieved complete healing of fistulae by 6-28 weeks and follow-up for mean 18 months.

Clinical Trial – Dexmedetomidine Versus Magnesium Sulphate for Caesarean Delivery

Regional anesthesia has become more popular in cesarean deliveries because most of the
parturients prefer being awake during the birth process. In addition, regional anesthesia may
be a safer method than general. In spinal anesthesia local anesthetics alone may not be
enough for an effective postoperative analgesia and hemodynamic stability of the patient wich
is crucial during cesarean section. So far many adjuvants have been used to augment the
analgesia produced by intrathecal local anesthetics and to reduce their adverse effects .

Various intrathecal adjuvants to local anaesthetics have found to improve the quality and
extend duration of spinal block. Prolongation of duration of spinal block is desirable both
for long procedures and for postoperative pain relief. Efficacy and safty of intrathecal
magnesium as analgesic adjuvant has been tested by several clinical trails in recent
years.Antinociceptive effect of magnesium appears to be relevant for the management of
chronic and post operative pain. These effects are primarily based on regulation of calcium
influx in to the cell. Magnesium blocks calcium influx and non competitively antagonizes NMDA
channels. NMDA receptor signelling plays an impartent in determining the duration of acute
pain3).) addition of magnesium to spinal anaesthesia improved postoperative analgesia in
orthopedic setting. addition of intrathecal magnesium sulfate to 10 mg bupivacaine plus 25µg
fentanyl prolonged spinal anaesthesia in patients undergoing lower extremity surgery.

Dexmedetomidine is a highly selective 2-adrenergic agonist which has been used as
pre-medication and as an adjuvant to general anesthesia.Dexmedetomidine have several
beneficial actions during perioperative period. They decrease sympathetic tone with
attenuation of the neuroendocrine and haemodynamic response to anaesthesia and surgery,
reduce anaesthetic and opiod requirement, cause sedation and analgesia. Dexmedetomidine was
first introduced into clinical practice as a short term intravenous sedative in intensive
care. Like any other adjuvant dexmedetomidine is not free from adverse effects. Use of
dexmedetomidine is often associated with a decrease in heart rate and blood
pressure.Dexmedetomidine was used to enhance the analgesic property of local anaesthetics
like lidocaine bupivacaine and ropivacaine. In vivo and in vitro studies indicated that these
local anaesthetics had significant neurotoxicity. Dexmedetomidine showed protective or growth
promoting properties in tissues, including nerve cells from cortex. Intrathecal
dexmedetomidine has a neuroprotective effect similar to methylprednisolone.

The mechanism by which intrathecal alpha 2-adrenergic agonists prolong the motor and sensory
block of local anesthetics is not clear. It may be an additive or synergistic effect
secondary to the different mechanisms of action of local anesthetic and alpha 2 adrenergic
agonist. The local anesthetics act by blocking sodium channels, whereas the alpha 2
adrenergic agonist acts by binding to pre synapyic C fibre and post synaptic dorsal horn
neurons. Intrathecal alpha 2 adrenergic agonist produce analgesia by depressing the realease
of C fibre transmission by hyperpolarization of post synaptic dorsal horn neurons. Li et al
observed that Glutamate is involved in excitatory neurotransmission nociception and plays an
essential role in relaying noxious stimuli in the spinal cord. Intrathecal injection of alpha
2 adrenergic agonists produces potent antinociceptive effects by altering spinal
neurotransmitter release and effectively treats acute pain.